Submitted by Anonymous (not verified) on 28 January 2026 - 14:14
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Aybintio, bevacizumab, Date of authorisation: 19/08/2020, Revision: 12, Status: Authorised